Stonebridge Capital Advisors LLC Novo Nordisk A S Transaction History

Stonebridge Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $46,743 - $102,563	514 Added 98.09%	1,038 $94,000
Q2 2023 Aug 23, 2023	BUY	$155.98 - $172.65 $42,894 - $47,478	275 Added 110.44%	524 $84,000
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $7,278 - $8,752	55 Added 28.35%	249 $39,000
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $512 - $676	5 Added 2.65%	194 $26,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $3,430 - $4,209	36 Added 23.53%	189 $19,000
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $10,260 - $11,600	153 New	153 $10,000
Q3 2020 Nov 18, 2020	SELL	$63.69 - $70.22 $7,961 - $8,777	-125 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $2,293 - $2,679	-46 Reduced 26.9%	125 $7,000
Q2 2019 Aug 15, 2019	BUY	$46.79 - $52.47 $8,001 - $8,972	171 New	171 $9,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.